Kjær SK - Search Results

1

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.

Yang X, Song H, Leslie G, Engel C, Hahnen E, Auber B, Horváth J, Kast K, Niederacher D, Turnbull C, Houlston R, Hanson H, Loveday C, Dolinsky JS, LaDuca H, Ramus SJ, Menon U, Rosenthal AN, Jacobs I, Gayther SA, Dicks E, Nevanlinna H, Aittomäki K, Pelttari LM, Ehrencrona H, Borg Å, Kvist A, Rivera B, Hansen TVO, Djursby M, Lee A, Dennis J, Bowtell DD, Traficante N, Diez O, Balmaña J, Gruber SB, Chenevix-Trench G, Investigators K, Jensen A, Kjær SK, Høgdall E, Castéra L, Garber J, Janavicius R, Osorio A, Golmard L, Vega A, Couch FJ, Robson M, Gronwald J, Domchek SM, Culver JO, de la Hoya M, Easton DF, Foulkes WD, Tischkowitz M, Meindl A, Schmutzler RK, Pharoah PDP, Antoniou AC. Yang X, et al. Among authors: kjaer sk. J Natl Cancer Inst. 2020 Dec 14;112(12):1242-1250. doi: 10.1093/jnci/djaa030. J Natl Cancer Inst. 2020. PMID: 32107557 Free PMC article.

2

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.

Høgdall EV, Høgdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, Vuust J, Nørgaard-Pedersen B, Kjaer SK. Høgdall EV, et al. Among authors: kjaer sk. Anticancer Res. 2002 May-Jun;22(3):1859-64. Anticancer Res. 2002. PMID: 12168882

3

K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study.

Høgdall EV, Høgdall CK, Blaakaer J, Christensen L, Bock JE, Vuust J, Glud E, Kjaer SK; Danish "Malova" Ovarian Cancer Study. Høgdall EV, et al. Among authors: kjaer sk. Gynecol Oncol. 2003 Apr;89(1):31-6. doi: 10.1016/s0090-8258(03)00005-2. Gynecol Oncol. 2003. PMID: 12694651

4

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK. Høgdall EV, et al. Among authors: kjaer sk. Cancer. 2003 Jul 1;98(1):66-73. doi: 10.1002/cncr.11476. Cancer. 2003. PMID: 12833457 Free article.

5

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Høgdall CK. Høgdall EV, et al. Among authors: kjaer sk. Oncol Rep. 2003 Sep-Oct;10(5):1535-8. Oncol Rep. 2003. PMID: 12883737

6

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.

Høgdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Høgdall CK. Høgdall EV, et al. Among authors: kjaer sk. Cancer. 2004 Jun 1;100(11):2387-95. doi: 10.1002/cncr.20213. Cancer. 2004. PMID: 15160342 Free article.

7

The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.

Begum FD, Høgdall CK, Kjaer SK, Christensen L, Blaakaer J, Bock JE, Glud E, Høyer-Hansen G, Ring-Larsen H, Høgdall EV. Begum FD, et al. Among authors: kjaer sk. Anticancer Res. 2004 May-Jun;24(3b):1981-5. Anticancer Res. 2004. PMID: 15274388 Free article.

8

Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.

Glud E, Kjaer SK, Thomsen BL, Høgdall C, Christensen L, Høgdall E, Bock JE, Blaakaer J. Glud E, et al. Among authors: kjaer sk. Arch Intern Med. 2004 Nov 8;164(20):2253-9. doi: 10.1001/archinte.164.20.2253. Arch Intern Med. 2004. PMID: 15534163

9

Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.

Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Hogdall E, Hogdall C, Stratton J, Whittemore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, Pharoah PD. Auranen A, et al. Among authors: kjaer sk. Int J Cancer. 2005 Nov 20;117(4):611-8. doi: 10.1002/ijc.21047. Int J Cancer. 2005. PMID: 15924337 Free article.

10

P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study.

Høgdall EV, Kjaer SK, Blaakaer J, Christensen L, Glud E, Vuust J, Høgdall CK. Høgdall EV, et al. Among authors: kjaer sk. Gynecol Oncol. 2006 Jan;100(1):76-82. doi: 10.1016/j.ygyno.2005.07.131. Epub 2005 Sep 23. Gynecol Oncol. 2006. PMID: 16183105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

688 results

Search Page